Dr Reddy's Laboratories Ltd (RDY)
13.99
-0.31
(-2.17%)
USD |
NYSE |
Nov 21, 16:00
14.08
+0.09
(+0.64%)
Pre-Market: 07:47
Dr Reddy's Laboratories Net Income (Quarterly): 149.84M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 149.84M |
| March 31, 2024 | 157.38M |
| December 31, 2023 | 165.60M |
| September 30, 2023 | 178.99M |
| June 30, 2023 | 170.71M |
| March 31, 2023 | 116.77M |
| December 31, 2022 | 151.87M |
| September 30, 2022 | 139.49M |
| June 30, 2022 | 153.93M |
| March 31, 2022 | 11.63M |
| December 31, 2021 | 94.25M |
| September 30, 2021 | 133.88M |
| June 30, 2021 | 77.40M |
| March 31, 2021 | 49.70M |
| December 31, 2020 | 2.677M |
| September 30, 2020 | 102.27M |
| June 30, 2020 | 76.04M |
| March 31, 2020 | 105.23M |
| December 31, 2019 | -79.90M |
| September 30, 2019 | 154.91M |
| June 30, 2019 | 95.13M |
| March 31, 2019 | 61.60M |
| December 31, 2018 | 67.25M |
| September 30, 2018 | 71.81M |
| June 30, 2018 | 68.04M |
| Date | Value |
|---|---|
| March 31, 2018 | 46.96M |
| December 31, 2017 | 51.69M |
| September 30, 2017 | 44.32M |
| June 30, 2017 | 9.163M |
| March 31, 2017 | 46.66M |
| December 31, 2016 | 69.74M |
| September 30, 2016 | 44.07M |
| June 30, 2016 | 18.88M |
| March 31, 2016 | 11.05M |
| December 31, 2015 | 87.86M |
| September 30, 2015 | 111.19M |
| June 30, 2015 | 98.68M |
| March 31, 2015 | 83.36M |
| December 31, 2014 | 92.74M |
| September 30, 2014 | 94.70M |
| June 30, 2014 | 92.02M |
| March 31, 2014 | 77.93M |
| December 31, 2013 | 99.73M |
| September 30, 2013 | 111.17M |
| June 30, 2013 | 64.83M |
| March 31, 2013 | 105.36M |
| December 31, 2012 | 69.82M |
| September 30, 2012 | 71.11M |
| June 30, 2012 | 62.33M |
| March 31, 2012 | 52.20M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-79.90M
Minimum
Dec 2019
178.99M
Maximum
Sep 2023
103.04M
Average
116.77M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| 111 Inc | -1.949M |
| Zai Lab Ltd | -41.67M |
| Infosys Ltd | 777.00M |
| SS Innovations International Inc | -1.172M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 956.87M |
| Total Expenses (Quarterly) | 741.47M |
| EPS Diluted (Quarterly) | 0.0359 |
| Enterprise Value | 11.47B |
| Gross Profit Margin (Quarterly) | 59.59% |
| Profit Margin (Quarterly) | 15.66% |
| Earnings Yield | 3.34% |
| Operating Earnings Yield | 6.77% |
| Normalized Earnings Yield | 2.842 |